A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate
Clinical trial NCT00740051 · COMPLETED
Trial details
- NCT number
- NCT00740051
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-08-01
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.